Clinical Trial: HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.

U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07233070) titled 'HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.' on Nov. 14.

Brief Summary: This study plans to enroll a total of 208 patients with Acute Ischemic Stroke (AIS) who present within 4.5 to 24 hours of symptom onset and meet the specified imaging criteria.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Acute Ischemic Stroke

Intervention: DRUG: HRS-7450 Injection

HRS-7450 Injection; low dose

DRUG: HRS-7450 Injection

HRS-7450 Injection; Intermediate dose

DRUG: HRS-7450 Injection

HRS-7450 Injection; high dose

DRUG: HRS-7450 Injection Placebo

HRS-7450 Injection Placebo

Recruitment Stat...